* STRATA Skin Sciences Inc SSKN.OQ SSKN.O is expected
to show a rise in quarterly revenue when it reports results on
November 10.
* The Horsham, Pennsylvania-based company is expected to report
a 34.1% increase in revenue to $7.527 million from $5.61 million
a year ago, according to the mean estimate from 2 analysts,
based on Refinitiv data.
* Refinitiv's mean analyst estimate for STRATA Skin Sciences
Inc is for a loss of 5 cents per share. For the same quarter
last year, the company reported a loss of 4 cents per share.
* The current average analyst rating on the shares is "strong
buy" and the breakdown of recommendations is 2 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in the
last three months.
* Wall Street's median 12-month price target for STRATA Skin
Sciences Inc is $13, about 85.7% above its last closing price
of $1.86.
* Previous quarterly performance (using preferred earnings
measure in US dollars).
QUARTER STARMINE REFINITIV ACTUAL BEAT, SURPRI
ENDING SMARTESTIM IBES MET, SE %
ATE® ESTIMATE MISSED
Jun. 30 2021 -0.05 -0.04 0.03 Beat 166.7
Mar. 31 2021 -0.04 -0.04 -0.07 Missed -75
Dec. 31 2020 -0.04 -0.03 -0.01 Beat 62.5
Sep. 30 2020 -0.05 -0.04 -0.04 Met -9.1
Jun. -0.05 -0.03 -0.05 Missed -50
30 2020
Mar. 31 2020 -0.07 -0.05 -0.03 Beat 43.7
Dec. 31 2019 -0.02 -0.02 0.00 Beat 87.1
This summary was machine generated November 9 at 03:07 GMT. All
figures in US dollars unless otherwise stated